Multiple Choice
Which chronic myeloproliferative disorder is treated with Imatinib mesylate (Gleevec) , a drug that inhibits tyrosine kinase?
A) Polycythemia vera
B) Chronic myelogenous leukemia
C) Essential thrombocythemia
D) Primary myelofibrosis
Correct Answer:
Verified
Correct Answer:
Verified
Related Questions
Q10: Bone marrow or stem cell transplantation is
Q11: What clinical feature is more often associated
Q12: Which of the following is the most
Q13: What do all chronic myeloproliferative disorders share?<br>A)
Q14: Which of the following is an expected
Q15: Which of the following is true for
Q15: A patient has a normal white blood
Q16: The Janus kinase (JAK) mutation is seen
Q17: A high red count, hemoglobin, and hematocrit
Q20: A patient has a platelet count of